|
Real-time Estimate
Cboe BZX
03:59:52 2026-10-20 pm EDT
|
5-day change | 1st Jan Change | ||
| 0.3602 USD | +4.10% |
|
-17.36% | -95.20% |
| Aug. 31 | Karyopharm Therapeutics Submits Supplemental New Drug Application to the Fda for Xpovio Plus Ruxolitinib for Patients with Myelofibrosis | CI |
| Aug. 29 | Karyopharm Therapeutics Inc. - Special Call |
Chart calendar Karyopharm Therapeutics Inc.
Upcoming events on Karyopharm Therapeutics Inc.
No events available
Past events on Karyopharm Therapeutics Inc.
| 2026-08-13 | Earnings presentation | 08:00 am |
| 2026-08-13 | Earnings release - Q2 2026 | |
| 2026-06-12 | Information meeting | |
| 2026-06-08 | Information meeting | 12:00 pm |
| 2026-06-02 | Information meeting | 02:00 pm |
| 2026-05-21 | Présentation aux Actionnaires / Analystes | 09:00 am |
| 2026-05-21 | Annual General Meeting | 09:00 am |
| 2026-05-14 | Earnings presentation | 08:00 am |
| 2026-05-14 | Earnings release - Q1 2026 | |
| 2026-03-24 | Information meeting | 08:00 am |
| 2026-02-17 | Extraordinary General Meeting | |
| 2026-02-12 | Earnings presentation | 08:00 am |
| 2026-02-12 | Earnings release - Q4 2025 | |
| 2025-11-03 | Earnings presentation | 08:00 am |
| 2025-11-03 | Earnings release - Q3 2025 |
Annual results
| Fiscal Period | December | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 146 146 0.09% | 145 150 -3.45% | 146 145 0.63% | 136 | 174 | 332 |
|
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -130 -125 -3.93% | -119 -116 -2.79% | -90,7 -96,1 5.58% | -98,7 | -60,2 | -2,65 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -143 -135 -5.64% | -76,4 -83,8 8.86% | -196 -121 -61.63% | -156 | -111 | -66,6 |
|
Net income Million USD | Released Forecast Spread | -143 -134 -6.48% | -76,4 -81,1 5.82% | -196 -123 -59.55% | -160 | -115 | -85,6 |
|
EPS USD | Released Forecast Spread | -18,7 -17,7 -6.16% | -9,45 -9,56 1.18% | -17,9 -12,3 -45.61% | -4,70 | -2,39 | -1,58 |
| Announcement Date | 29/02/24 | 19/02/25 | 12/02/26 | - |
Quarterly results
| Fiscal Period | June | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 Q3 | 2026 Q4 | 2027 Q1 | 2027 Q2 | 2027 Q3 | 2027 Q4 | 2028 Q1 | 2028 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 30,5 35,7 -14.39% | 30,0 35,1 -14.54% | 37,9 37,9 0.01% | 44,0 42,4 3.85% | 34,1 33,2 2.77% | 35,1 31,4 11.68% | 33,4 32,2 3.85% | 33,5 | 34,3 | 34,3 | 37,3 | 44,9 | 53,6 | 77,4 | 112 |
|
EBIT Million USD | Released Forecast Spread | -31,3 -28,0 -11.57% | -33,3 -27,5 -20.84% | -24,4 -24,6 0.89% | -15,2 -20,8 26.84% | -17,8 -23,2 23.01% | -26,8 -23,0 -16.29% | -22,5 -28,3 20.48% | -25,8 | -23,6 | -19,2 | -16,4 | -13,2 | -9,20 | -10,2 | -2,20 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -30,9 -38,3 19.37% | -23,4 -36,4 35.62% | -37,2 -32,4 -14.7% | -33,1 -30,3 -9.12% | -102 -28,5 -259.3% | -22,4 -28,0 19.9% | -67,0 -32,4 -106.99% | -34,8 | -33,8 | -29,3 | -26,6 | -23,6 | -19,8 | -14,6 | -6,30 |
|
Net income Million USD | Released Forecast Spread | -30,8 -35,5 13.39% | -23,5 -35,4 33.71% | -37,3 -31,6 -17.78% | -33,1 -28,7 -15.49% | -102 -29,0 -252.05% | -22,4 -29,3 23.69% | -67,0 -33,0 -103.22% | -36,1 | -35,2 | -30,6 | -28,0 | -25,0 | -21,3 | -18,0 | -10,3 |
|
EPS USD | Released Forecast Spread | -3,60 -4,05 11.11% | -2,77 -4,28 35.31% | -4,32 -4,03 -7.2% | -3,82 -3,52 -8.44% | -5,71 -2,04 -180.59% | -1,24 -1,49 16.78% | -2,32 -1,42 -62.92% | -0,84 | -0,78 | -0,70 | -0,63 | -0,55 | -0,46 | -0,17 | -0,10 |
| Announcement Date | 19/02/25 | 12/05/25 | 11/08/25 | 03/11/25 | 12/02/26 | 14/05/26 | 13/08/26 | - | - | - | - | - | - | - | - |
| 2026-10-21 |  | Earnings release - Q3 2026 | |
| 2026-10-21 | | Earnings release - Q3 2026 | |
| 2026-10-22 | | Earnings release - Q3 2026 | |
| 2026-10-22 | | Earnings presentation | 04:00 am |
| 2026-10-22 | | Earnings release - Q3 2026 | |
| 2026-10-22 | | Earnings release - Q3 2026 | 02:00 am |
| 2026-10-22 | | Earnings presentation | 03:30 am |
| 2026-10-23 | | Earnings release - Q3 2026 | |
| 2026-10-23 | | Earnings release - Q3 2026 | |
| 2026-10-23 | | Information meeting | 08:00 am |
Past sector events for Karyopharm Therapeutics Inc.
| 2026-10-15 | | Extraordinary General Meeting | 03:00 am |
| 2026-10-15 | | Extraordinary General Meeting | 02:00 am |
| 2026-10-13 | | Sales and Revenue Release - Q3 2026 | |
| 2026-10-13 | | Extraordinary General Meeting | 02:30 am |
| 2026-10-12 | | Extraordinary General Meeting | 09:30 pm |
| 2026-10-09 | | Earnings presentation | 03:00 am |
| 2026-10-09 | | Extraordinary General Meeting | 02:30 am |
| 2026-10-08 | | Earnings presentation | 09:00 pm |
| 2026-10-02 | | Ex-dividend date - 0.99325 KRW | 12:00 am |
| 2026-10-01 | | Information meeting | 08:30 am |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Stocks
- KPTI Stock
- Calendar Karyopharm Therapeutics Inc.
Select your edition
All financial news and data tailored to specific country editions
